Discover why Recursion Pharmaceuticals, Inc. stands out in AI drug discovery, but faces valuation risks. Click for my look at ...

With the rapid advancements in computer technology and bioinformatics, the prediction of protein-ligand binding sites has ...

DUBLIN--(BUSINESS WIRE)--The "AI in Biotechnology: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for AI in biotechnology was valued at $3.8 billion in ...

Warner Bros. Discovery said it is open to a sale as it expands its strategic review. CNBC's David Faber breaks down the latest details. Judge Strikes Down Gun Ban in Major Ruling Urgent warning issued ...

In traditional drug discovery, it can take an entire decade and in excess of a billion dollars to successfully bring a drug to market. Despite the best efforts of scientists, around 90% of proposed ...

In an era marked by mounting drug shortages and a historic shift away from mandatory animal testing, the pharmaceutical landscape is undergoing rapid transformation. Hybrid AI, technology that ...

Warner Bros. Discovery is reviewing “strategic alternatives” in light of “unsolicited interest” it has received from multiple parties for both the entire company and the standalone Warner Bros.

Neve Yarak, Israel, Oct. 30, 2025 (GLOBE NEWSWIRE) -- N2OFF, Inc. (NASDAQ: NITO) (“N2OFF” and the “Company”), a cleantech company investing in solar energy assets based on the RTB (Ready to Build) ...

How do cells, containing billions of biomolecules each, orchestrate the biochemical processes required for performing a diverse range of cellular functions? The biomolecules are organized in time and ...

Human organoids provide physiologically relevant, 3D models for studying disease mechanisms, drug efficacy and toxicity. This Review examines organoid generation methods, applications in preclinical ...